［1］Travis WD，Gal AA，Colby TV，Klimstra DS，Falk R，Koss MN.Reproducibility of neuroendocrine lung tumor classification.Human pathology 1998，29（3）：272-279

［2］Asamura H，Kameya T，Matsuno Y，et al.Neuroendocrine neoplasms of the lung：aprognostic spectrum.Journal of clinical oncology：official journal of the American Society of Clinical Oncology 2006，24 （1）：70-76

［3］Babakoohi S，Fu P，Yang M，Linden PA，Dowlati A.Combined SCLC Clinical and Pathologic Characteristics.Clinical lung cancer 2012

［4］Nicholson SA，Beasley MB，Brambilla E，et al.Small cell lung carcinoma（SCLC）：a clinicopathologic study of 100cases with surgical specimens.The American journal of surgical pathology 2002，26（9）：1184-97

［5］Vignoli M，Rossi F，Chierici C，et al.Needle tract implantation after fine needle aspiration biopsy（FNAB）of transitional cell carcinoma of the urinary bladder and adenocarcinoma of the lung.Schweizer Archiv fur Tierheilkunde 2007，149（7）：314-318

［6］Chivukula M，Dincer HE，Biller JA，Krouwer HG，Simon G，Shidham V.FNAB cytology of extra-cranial metastasis of glioblastoma multiforme may resemble a lung primary：a diagnostic pitfall.CytoJournal 2005，2：9

［7］Mohapatra PR，Saini V.Comparison of accuracy and safety of CT guided and unguided transthoracic FNAB in diagnosis of lung lesions.The Journal of the Association of Physicians of India 2003，51：88，author reply

［8］Kuo CH，Chen HC，Chung FT，et al.Diagnostic value of EBUS-TBNA for lung cancer with non-enlarged lymph nodes：a study in a tuberculosis-endemic country.PloS one 2011，6（2）：e16877

［9］Fielding D，Bashirzadeh F，Nguyen P，Hodgson A，Daniel J.［Review of the role of EBUS-TBNA for the pulmonologist，including lung cancer staging］.Zhongguo fei ai za zhi=Chinese journal of lung cancer 2010，13（5）：410-417

［10］Zhao X，Wang M.［The role of TBNA in diagnosis and treatment of lung diseases］.Zhongguo fei ai za zhi=Chinese journal of lung cancer 2010，13（5）：396-400

［11］Krasnik M.［EBUS-TBNA and EUS-FNA in diagnostics and staging of lung cancer］.Ugeskrift for laeger 2009，171（13）：1095

［12］Zhang SY，Wang X，Zhu ZH，et al.［Clinical value of cervical mediastinoscopy in non-small cell lung cancer of stage I］.Ai zheng=Aizheng=Chinese journal of cancer 2005，24（3）：349-352

［13］Sivrikoz CM，Ak I，Simsek FS，Doner E，Dundar E.Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma？The Thoracic and cardiovascular surgeon 2012，60（2）：116-121

［14］Zhang L，Mao F，Cai M，Shen-Tu Y.［A Comparative Study on the Diagnosis and Staging of Lung Cancer between Mediastinoscopy and EBUS-TBNA］.Zhongguo fei ai za zhi=Chinese journal of lung cancer 2013，16（6）：289-293

［15］Kondo K，Adachi H.［Minimally invasive surgery for lung cancer using thoracoscope as a′microscopic surgery′，for the safety endoscopic surgery］.Kyobu geka The Japanese journal of thoracic surgery 2006，59（8Suppl）：703-709

［16］Gu L，Wu Y.［Application of thoracoscope on the diagnosis and multimodality therapy of lung cancer］. Zhongguo fei ai za zhi=Chinese journal of lung cancer 2001，4（4）：257-262

［17］Zaharopoulos P，Wong JY，Stewart GD.Cytomorphology of the variants of small-cell carcinoma of the lung.Acta cytologica 1982，26（6）：800-808

［18］Mullins RK，Thompson SK，Coogan PS，Shurbaji MS.Paranuclear blue inclusions：an aid in the cytopathologic diagnosis of primary and metastatic pulmonary small-cell carcinoma.Diagnostic cytopathology 1994，10（4）：332-335

［19］Walker WP，Wittchow RJ，Bottles K，Layfield LJ，Hirschowitz S，Cohen MB.Paranuclear blue inclusions in small cell undifferentiated carcinoma：a diagnostically useful finding demonstrated in fine-needle aspiration biopsy smears.Diagnostic cytopathology 1994，10（3）：212-215

［20］Sakr L，Roll P，Payan MJ，et al.Cytology-based treatment decision in primary lung cancer：is it accurate enough？Lung cancer 2012，75（3）：293-299

［21］Curran WJ，Jr.Therapy of limited stage small cell lung cancer.Cancer treatment and research 2001，105：229-252

［22］Fournel P.Limited-stage small cell lung cancer：how to optimize therapy？Onkologie 2012，35（6）：332-333

［23］Hiroshima K，Iyoda A，Shida T，et al.Distinction of pulmonary large cell neuroendocrine carcinoma from small cell lung carcinoma：a morphological，immunohistochemical，and molecular analysis.Modern pathology：an official journal of the United States and Canadian Academy of Pathology，Inc 2006，19（10）：1358-1368

［24］den Bakker MA，Willemsen S，Grunberg K，et al.Small cell carcinoma of the lung and large cell neuroendocrine carcinoma interobserver variability.Histopathology 2010，56（3）：356-363

［25］Singh N.Classification of large cell neuroendocrine carcinoma：at the cross roads of small and non-small cell lung cancer.Journal of thoracic oncology：official publication of the International Association for the Study of Lung Cancer 2011，6（7）：1298-1299

［26］Austin JH，Yip R，D′Souza BM，Yankelevitz DF，Henschke CI，International Early Lung Cancer Action Program I.Small-cell carcinoma of the lung detected by CT screening：stage distribution and curability.Lung cancer 2012，76（3）：339-343

［27］Grunnet M，Sorensen JB.Carcinoembryonic antigen（CEA）as tumor marker in lung cancer.Lung cancer 2012，76（2）：138-143

［28］Lyda MH，Weiss LM.Immunoreactivity for epithelial and neuroendocrine antibodies are useful in the differential diagnosis of lung carcinomas.Human pathology 2000，31（8）：980-987

［29］Sorhaug S，Steinshamn S，Haaverstad R，Nordrum IS，Martinsen TC，Waldum HL.Expression of neuroendocrine markers in non-small cell lung cancer.APMIS：acta pathologica，microbiologica，et immunologica Scandinavica 2007，115（2）：152-163

［30］Brambilla E，Negoescu A，Gazzeri S，et al.Apoptosis-related factors p53，Bcl2，and Bax in neuroendocrine lung tumors.The American journal of pathology 1996，149（6）：1941-1952

［31］Johansson L.Histopathologic classification of lung cancer：Relevance of cytokeratin and TTF-1immunophenotyping.Annals of diagnostic pathology 2004，8（5）：259-267

［32］Naeem M，Dahiya M，Clark JI，Creech SD，Alkan S.Analysis of c-kit protein expression in small-cell lung carcinoma and its implication for prognosis.Human pathology 2002，33（12）：1182-1187

［33］Folpe AL，Gown AM，Lamps LW，et al.Thyroid transcription factor-1：immunohistochemical evaluation in pulmonary neuroendocrine tumors.Modern pathology：an official journal of the United States and Canadian Academy of Pathology，Inc 1999，12（1）：5-8

［34］Kaufmann O，Dietel M.Expression of thyroid transcription factor-1in pulmonary and extrapulmonary small cell carcinomas and other neuroendocrine carcinomas of various primary sites.Histopathology 2000，36（5）：415-420

［35］Zhao P，Hou N，Shao Y，Li XH.［Clinicopathological significance of expression of c-kit protein in neuroendocrine lung carcinoma］.Zhonghua yi xue za zhi 2005，85（22）：1526-1529

［36］Petersen I，Hidalgo A，Petersen S，et al.Chromosomal imbalances in brain metastases of solid tumors.Brain pathology 2000，10（3）：395-401

［37］Onuki N，Wistuba，II，Travis WD，et al.Genetic changes in the spectrum of neuroendocrine lung tumors.Cancer 1999，85（3）：600-607

［38］Cacciotti P，Libener R，Betta P，et al.SV40replication in human mesothelial cells induces HGF/Met receptor activation：a model for viral-related carcinogenesis of human malignant mesothelioma.Proceedings of the National Academy of Sciences of the United States of America 2001，98（21）：12032-12037

［39］Nicholson SA，Okby NT，Khan MA，et al.Alterations of p14ARF，p53，and p73genes involved in the E2F-1-mediated apoptotic pathways in non-small cell lung carcinoma.Cancer research 2001，61（14）：5636-5643

［40］Hida T，Yatabe Y，Achiwa H，et al.Increased expression of cyclooxygenase 2occurs frequently in human lung cancers，specifically in adenocarcinomas.Cancer research 1998，58（17）：3761-3764

［41］Marrogi AJ，Travis WD，Welsh JA，et al.Nitric oxide synthase，cyclooxygenase 2，and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma.Clinical cancer research：an official journal of the American Association for Cancer Research 2000，6（12）：4739-4744

［42］Johnson BE，Russell E，Simmons AM，et al.MYC family DNA amplification in 126tumor cell lines from patients with small cell lung cancer.Journal of cellular biochemistry Supplement 1996，24：210-217

［43］Robles AI，Linke SP，Harris CC.The p53network in lung carcinogenesis.Oncogene 2002，21（45）：6898-6907

［44］Bhattacharjee A，Richards WG，Staunton J，et al.Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses.Proceedings of the National Academy of Sciences of the United States of America 2001，98（24）：13790-13795

［45］Garber ME，Troyanskaya OG，Schluens K，et al.Diversity of gene expression in adenocarcinoma of the lung.Proceedings of the National Academy of Sciences of the United States of America 2001，98（24）：13784-13789

［46］Zhang H，Liu J，Cagle PT，Allen TC，Laga AC，Zander DS.Distinction of pulmonary small cell carcinoma from poorly differentiated squamous cell carcinoma：an immunohistochemical approach.Modern pathology：an official journal of the United States and Canadian Academy of Pathology，Inc 2005，18（1）：111-118

［47］Nagashio R，Sato Y，Matsumoto T，et al.Significant high expression of cytokeratins 7，8，18，19in pulmonary large cell neuroendocrine carcinomas，compared to small cell lung carcinomas.Pathology international 2010，60（2）：71-77

［48］Hoshi R，Furuta N，Horai T，Ishikawa Y，Miyata S，Satoh Y.Discriminant model for cytologic distinction of large cell neuroendocrine carcinoma from small cell carcinoma of the lung.Journal of thoracic oncology：official publication of the International Association for the Study of Lung Cancer 2010，5（4）：472-478

［49］Nitadori J，Ishii G，Tsuta K，et al.Immunohistochemical differential diagnosis between large cell neuroendocrine carcinoma and small cell carcinoma by tissue microarray analysis with a large antibody panel.American journal of clinical pathology 2006，125（5）：682-692

［50］Rossi G，Marchioni A，Milani M，et al.TTF-1，cytokeratin 7，34betaE12，and CD56/NCAM immunostaining in the subclassification of large cell carcinomas of the lung.American journal of clinical pathology 2004，122（6）：884-893

［51］Wang SY，Zhu L，Li SM.［2005 WHO histological classification of tumours of the nasopharynx and TNM classification of carcinoma］.Zhonghua er bi yan hou tou jing wai ke za zhi=Chinese journal of otorhinolaryngology head and neck surgery 2007，42（8）：638-640